Ian Wisenberg has over 30 years of experience in international business, business development, corporate development, access to capital and finance, and in establishing strategic financial partnerships with local, national and international institutions.
Mr Wisenberg has been the executive chair of BioCina since March 2023, having been its chief executive for 2.5 years prior. He is also the operating partner and Australasia representative of Bridgewest Group, a US private investment firm which acquired BioCina (Pfizer's manufacturing facility in Adelaide) in late 2020.